2020 Annual Meeting | N3 - Neuroscience in the Clinic: Melatonin and Disrupted Sleep in Neurologic Disorders

Date Tuesday 04/28/20

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Temitayo Oyegbile-Chidi, MD, PhD, FAAN, Amy Gelfand, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Upon completion, participants should be familiar with sleep abnormalities observed in multiple neurologic disorders and how melatonin may affect neurologic function.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based

Event Timeline
03:30 PM - 03:40 PM	Introduction	General Overview: Specific Neurologic Disorders and Disrupted Sleep: Highlighting the Role of Melatonin Temitayo Oyegbile-Chidi, MD, PhD, FAAN
03:40 PM - 03:50 PM	Speaker	Clinical Vignette: Sleep Disruption and Migraine Amy Gelfand, MD
03:50 PM - 04:20 PM	Speaker	Sleep, Clocks, and Melatonin in Neurologic Disorders Aleksandar Videnovic, MD, MSc, FAAN
04:20 PM - 04:35 PM	Abstract	001 - A Computational Model of the Role of Melatonin in the Pathogenesis and Disrupted Sleep in Multiple Sclerosis João Marcos Brandet
04:35 PM - 04:50 PM	Abstract	002 - Peak Seizure Frequency Correlates with Disruptive Spiking in Rapid Eye Movement Sleep Marcus Ng, MD
04:50 PM - 05:05 PM	Speaker	Strategies to Modulate Melatonin to Affect Sleep Temitayo Oyegbile-Chidi, MD, PhD, FAAN
05:05 PM - 05:15 PM	Speaker	Clinical Vignette Wrap Up Amy Gelfand, MD
05:15 PM - 05:30 PM	Discussion	Panel Discussion

Faculty Disclosures
Aleksandar Videnovic, MD, MSc, FAAN	Dr. Videnovic has nothing to disclose.
Temitayo Oyegbile-Chidi, MD, PhD, FAAN	Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Spectrum. Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Elite Medical. The institution of Dr. Oyegbile-Chidi has received research support from NIH.
Michelle Lee Jones, MD	No disclosure on file
Amy Gelfand, MD	Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Headache Society. The institution of an immediate family member of Dr. Gelfand has received research support from Roche/Genentech. The institution of an immediate family member of Dr. Gelfand has received research support from Vigil Neuroscience. The institution of Dr. Gelfand has received research support from UCSF Resource Allocation Program. The institution of an immediate family member of Dr. Gelfand has received research support from NIH/NINDS. The institution of an immediate family member of Dr. Gelfand has received research support from National MS Society. The institution of Dr. Gelfand has received research support from PCORI. Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Witness with United States Department of Health and Human Services, Vaccine Injury Compensation Program. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Headache Cooperative of the Pacific. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Taiwan Headache Society. An immediate family member of Dr. Gelfand has a non-compensated relationship as a Clinical Trial Steering Committee Member with Roche/Genentech that is relevant to AAN interests or activities.
Marcus Ng, MD	The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
Aoife M. O'Carroll, MD	No disclosure on file
Marna McKenzie	No disclosure on file
	No disclosure on file
João Marcos Brandet	Mr. Brandet has nothing to disclose.

��ɫ��

��ɫ��